Speaker

Lili Belcastro

Associate Director, Raw Materials, Drug Product Process Development, Bristol Myers Squibb

Lili Belcastro, Associate Director, Raw Materials, Drug Product Process Development at Bristol Myers Squibb, is speaking at 3rd Raw Materials for Cell & Gene Therapy Summit (San Diego, United States of America, 26–28 Oct 2026) in the session “When Materials Fail: How Risk Ranking & Supplier Engagement Transformed Our Strategy”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

3rd Raw Materials for Cell & Gene Therapy Summit
26–28 Oct 2026San Diego, United States of America
- SpeakerWhen Materials Fail: How Risk Ranking & Supplier Engagement Transformed Our Strategy
- PanelPanel Session: Navigating Supplier Diversification to Reduce Risk & Maintain Product ContinuityWith Shawn Wang

More speakers at 3rd Raw Materials for Cell & Gene Therapy Summit

James Adams
Chief Technical Officer, Tr1x therapeutics
Daniel Anaya
Associate Director, MS&T, Ray Therapeutics
Alison Burkart
Director, Analytical Development, Astellas Pharma
Benjamin Cho
Technical Development Scientist II, Genentech
Ben Clarke
Senior Scientist, Global Biologics, U.S. Pharmacopeia
Basak Clements
Independent Raw Materials Expert & USP CGT Expert Committee Member, Independent Expert

See all 17 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Lili Belcastro, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].